[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Hinchcliff, E., Westin, S.N. and Herzog, T.J. (2022) State of the Science: Contemporary Front-Line Treatment of Advanced Ovarian Cancer. Gynecologic Oncology, 166, 18-24. https://doi.org/10.1016/j.ygyno.2022.04.021
|
[3]
|
Jayson, G.C., Kohn, E.C., Kitchener, H.C., et al. (2014) Ovarian Cancer. Lancet, 384, 1376-1388.
https://doi.org/10.1016/S0140-6736(13)62146-7
|
[4]
|
Colombo, N., Sessa, C., du Bois, A., et al. (2019) ESMO-ESGO Consensus Conference Recommendations on Ovarian Cancer: Pathology and Molecular Biology, Early and Advanced Stages, Borderline Tumours and Recurrent Diseasedagger. Annals of Oncology, 30, 672-705. https://doi.org/10.1093/annonc/mdz062
|
[5]
|
Pierce, S.R. and Clark, L.H. (2018) Current First-line Therapy for Ovarian Cancer: A Comprehensive Review. Obstetrical & Gynecological Survey, 73, 650-657. https://doi.org/10.1097/OGX.0000000000000613
|
[6]
|
Qiao, L., Chen, X., Xi, X., et al. (2020) Correlation Analy-sis and Clinical Significance of CA125, HE4, DDI, and FDP in Type II Epithelial Ovarian Cancer. Medicine, 99, e23329. https://doi.org/10.1097/MD.0000000000023329
|
[7]
|
Zapardiel, I., Diestro, M.D. and Aletti, G. (2014) Conserva-tive Treatment of Early Stage Ovarian Cancer: Oncological and Fertility Outcomes. European Journal of Surgical On-cology, 40, 387-393.
https://doi.org/10.1016/j.ejso.2013.11.028
|
[8]
|
Yang, W.L., Lu, Z. and Bast, R.J. (2017) The Role of Biomarkers in the Management of Epithelial Ovarian Cancer. Expert Review of Molecular Diagnostics, 17, 577-591. https://doi.org/10.1080/14737159.2017.1326820
|
[9]
|
李飞霞, 田刚, 余婷, 等. 血清CA125、HE4联合PLR、NLR、MLR诊断上皮性卵巢癌的临床价值[J]. 山东医药, 2020, 60(10): 70-72.
|
[10]
|
Xu, X., Wu, Y., Jia, G., et al. (2023) A Signature Based on Glycosyltransferase Genes Provides a Promising Tool for the Prediction of Prognosis and Immunotherapy Responsiveness in Ovarian Cancer. Journal of Ovarian Research, 16, Article No. 5. https://doi.org/10.1186/s13048-022-01088-9
|
[11]
|
Arneth, B. (2019) Tumor Microenvironment. Medicina, 56, Ar-ticle 15. https://doi.org/10.3390/medicina56010015
|
[12]
|
Kulbe, H., Chakravarty, P., Leinster, D.A., et al. (2012) A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment. Cancer Research, 72, 66-75. https://doi.org/10.1158/0008-5472.CAN-11-2178
|
[13]
|
Mehla, K. and Hollingsworth, M.A. (2022) Inflam-matory and Immune Effects on Tumor Progression. Trends in Immunology, 43, 93-95. https://doi.org/10.1016/j.it.2021.11.009
|
[14]
|
杨庆利, 冷静. TLR2和TLR4信号在肿瘤发生和发展中的作用及机制的研究进展[J]. 中国免疫学杂志, 2021, 37(3): 382-386.
|
[15]
|
谢溦, 刘小燕, 温晓春, 等. 卵巢癌组织支原体感染及TLR2 mRNA、TLR4 mRNA、NF-κB mRNA表达及意义[J]. 中华医院感染学杂志, 2023, 33(6): 884-888.
|
[16]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? Lancet, 357, 539-545.
https://doi.org/10.1016/S0140-6736(00)04046-0
|
[17]
|
Rodriguez-Vita, J. and Lawrence, T. (2010) The Resolution of Inflammation and Cancer. Cytokine & Growth Factor Reviews, 21, 61-65. https://doi.org/10.1016/j.cytogfr.2009.11.006
|
[18]
|
Ritter, B. and Greten, F.R. (2019) Modulating Inflammation for Cancer Therapy. Journal of Experimental Medicine, 216, 1234-1243. https://doi.org/10.1084/jem.20181739
|
[19]
|
Crusz, S.M. and Balkwill, F.R. (2015) Inflammation and Cancer: Ad-vances and New Agents. Nature Reviews Clinical Oncology, 12, 584-596. https://doi.org/10.1038/nrclinonc.2015.105
|
[20]
|
Kusumanto, Y.H., Dam, W.A., Hospers, G.A., et al. (2003) Plate-lets and Granulocytes, in Particular the Neutrophils, form Important Compartments for Circulating Vascular Endothelial Growth Factor. Angiogenesis, 6, 283-287.
https://doi.org/10.1023/B:AGEN.0000029415.62384.ba
|
[21]
|
Ceran, M.U., Tasdemir, U., Colak, E., et al. (2019) Can Complete Blood Count Inflammatory Parameters in Epithelial Ovarian Cancer Contribute to Prognosis?—A Survival Analysis. Journal of Ovarian Research, 12, Article No. 16.
https://doi.org/10.1186/s13048-019-0491-7
|
[22]
|
Modugno, F., Ness, R.B., Allen, G.O., et al. (2004) Oral Contra-ceptive Use, Reproductive History, and Risk of Epithelial Ovarian Cancer in Women with and without Endometriosis. American Journal of Obstetrics and Gynecology, 191, 733-740. https://doi.org/10.1016/j.ajog.2004.03.035
|
[23]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674.
https://doi.org/10.1016/j.cell.2011.02.013
|
[24]
|
Mantovani, A., Allavena, P., Sica, A., et al. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
https://doi.org/10.1038/nature07205
|
[25]
|
Mantovani, A., Cassatella, M.A., Costantini, C., et al. (2011) Neutrophils in the Activation and Regulation of Innate and Adaptive Immunity. Nature Reviews Immunology, 11, 519-531. https://doi.org/10.1038/nri3024
|
[26]
|
Coffelt, S.B., Kersten, K., Doornebal, C.W., et al. (2015) IL-17-Producing Gammadelta T Cells and Neutrophils Conspire to Promote Breast Cancer Metastasis. Nature, 522, 345-348. https://doi.org/10.1038/nature14282
|
[27]
|
Lee, W., Ko, S.Y., Mohamed, M.S., et al. (2019) Neutrophils Facilitate Ovarian Cancer Premetastatic Niche Formation in the Omentum. Journal of Experimental Medicine, 216, 176-194. https://doi.org/10.1084/jem.20181170
|
[28]
|
Ocana, A., Nieto-Jimenez, C., Pandiella, A., et al. (2017) Neutrophils in Cancer: Prognostic Role and Therapeutic Strategies. Molecular Cancer, 16, Article No. 137. https://doi.org/10.1186/s12943-017-0707-7
|
[29]
|
Labelle, M., Begum, S. and Hynes, R.O. (2011) Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis. Cancer Cell, 20, 576-590.
https://doi.org/10.1016/j.ccr.2011.09.009
|
[30]
|
Schumacher, D., Strilic, B., Sivaraj, K.K., et al. (2013) Plate-let-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 Receptor. Cancer Cell, 24, 130-137.
https://doi.org/10.1016/j.ccr.2013.05.008
|
[31]
|
Yao, B., Qu, S., Hu, R., et al. (2019) Delivery of Platelet TPM3 mRNA into Breast Cancer Cells via Microvesicles Enhances Metastasis. FEBS Open Bio, 9, 2159-2169. https://doi.org/10.1002/2211-5463.12759
|
[32]
|
Hu, Q., Hisamatsu, T., Haemmerle, M., et al. (2017) Role of Plate-let-Derived Tgfbeta1 in the Progression of Ovarian Cancer. Clinical Cancer Research, 23, 5611-5621. https://doi.org/10.1158/1078-0432.CCR-16-3272
|
[33]
|
Haemmerle, M., Bottsford-Miller, J., Pradeep, S., et al. (2016) FAK Regulates Platelet Extravasation and Tumor Growth after Antiangiogenic Therapy Withdrawal. Journal of Clinical Investigation, 126, 1885-1896.
https://doi.org/10.1172/JCI85086
|
[34]
|
Zuo, X.X., Yang, Y., Zhang, Y., et al. (2019) Platelets Promote Breast Cancer Cell MCF-7 Metastasis by Direct Interaction: Surface Integrin α2β1-Contacting-Mediated Activation of Wnt-Beta-Catenin Pathway. Cell Communication and Signaling, 17, Article No. 142. https://doi.org/10.1186/s12964-019-0464-x
|
[35]
|
Guo, Y., Cui, W., Pei, Y., et al. (2019) Platelets Promote Invasion and Induce Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by TGF-Beta Signaling Pathway. Gynecologic Oncology, 153, 639-650.
https://doi.org/10.1016/j.ygyno.2019.02.026
|
[36]
|
Haemmerle, M., Stone, R.L., Menter, D.G., et al. (2018) The Platelet Lifeline to Cancer: Challenges and Opportunities. Cancer Cell, 33, 965-983. https://doi.org/10.1016/j.ccell.2018.03.002
|
[37]
|
Hu, B., Yang, X.R., Xu, Y., et al. (2014) Systemic Im-mune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222.
https://doi.org/10.1158/1078-0432.CCR-14-0442
|
[38]
|
Pollard, J.W. (2004) Tumour-Educated Macrophages Pro-mote Tumour Progression and Metastasis. Nature Reviews Cancer, 4, 71-78. https://doi.org/10.1038/nrc1256
|
[39]
|
Hu, P., Shen, H., Wang, G., et al. (2014) Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study. PLOS ONE, 9, e108062.
https://doi.org/10.1371/journal.pone.0108062
|
[40]
|
Zhang, S., Zhang, F., Sheng, X., et al. (2015) Decreased Pre-treatment Lymphocyte/Monocyte Ratio Is Associated with Poor Prognosis in Stage Ib-IIa Cervical Cancer Patients Who Undergo Radical Surgery. OncoTargets and Therapy, 8, 1355-1362. https://doi.org/10.2147/OTT.S82174
|
[41]
|
Huang, J., Li, Y., Xia, Y., et al. (2013) Prognostic Significance of Pe-ripheral Monocyte Count in Patients with Extranodal Natural Killer/T-Cell Lymphoma. BMC Cancer, 13, Article No. 222. https://doi.org/10.1186/1471-2407-13-222
|
[42]
|
Huang, H, Liu, Q., Zhu, L., et al. (2019) Prognostic Value of Pre-operative Systemic Immune-Inflammation Index in Patients with Cervical Cancer. Scientific Reports, 9, Article No. 3284. https://doi.org/10.1038/s41598-019-39150-0
|
[43]
|
Goh, B.K., Chok, A.Y., Allen, J.J., et al. (2016) Blood Neutro-phil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios are Independent Prognostic Factors for Surgically Resected Gas-trointestinal Stromal Tumors. Surgery, 159, 1146-1156.
https://doi.org/10.1016/j.surg.2015.10.021
|
[44]
|
Han, S., Liu, Y., Li, Q., et al. (2015) Pre-Treatment Neutro-phil-to-Lymphocyte Ratio Is Associated with Neutrophil and T-Cell Infiltration and Predicts Clinical Outcome in Patients with Glioblastoma. BMC Cancer, 15, Article No. 617.
https://doi.org/10.1186/s12885-015-1629-7
|
[45]
|
Zhang, G.M., Zhu, Y., Ma, X.C., et al. (2015) Pretreatment Neu-trophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiv-ing Radical Prostatectomy. Medicine, 94, e1473.
https://doi.org/10.1097/MD.0000000000001473
|
[46]
|
Asano, Y., Kashiwagi, S., Onoda, N., et al. (2016) Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer. Annals of Surgical Oncology, 23, 1104-1110.
https://doi.org/10.1245/s10434-015-4934-0
|
[47]
|
Bailey, S.E., Ukoumunne, O.C., Shephard, E., et al. (2017) How Useful Is Thrombocytosis in Predicting an Underlying Cancer in Primary Care? A Systematic Review. Family Practice, 34, 4-10. https://doi.org/10.1093/fampra/cmw100
|
[48]
|
Stone, R.L., Nick, A.M., McNeish, I.A., et al. (2012) Para-neoplastic Thrombocytosis in Ovarian Cancer. The New England Journal of Medicine, 366, 610-618. https://doi.org/10.1056/NEJMoa1110352
|
[49]
|
Sasaki, K., Kawai, K., Tsuno, N.H., et al. (2012) Impact of Preoper-ative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer. World Journal of Surgery, 36, 192-200. https://doi.org/10.1007/s00268-011-1329-7
|
[50]
|
Schlesinger, M. (2018) Role of Platelets and Platelet Receptors in Cancer Metastasis. Journal of Hematology & Oncology, 11, Article No. 125. https://doi.org/10.1186/s13045-018-0669-2
|
[51]
|
Kwon, H.C., Kim, S.H., Oh, S.Y., et al. (2012) Clinical Signifi-cance of Preoperative Neutrophil-Lymphocyte versus Platelet-Lymphocyte Ratio in Patients with Operable Colorectal Cancer. Biomarkers, 17, 216-222.
https://doi.org/10.3109/1354750X.2012.656705
|
[52]
|
Bhatti, I., Peacock, O., Lloyd, G., et al. (2010) Preoperative Hematologic Markers as Independent Predictors of Prognosis in Resected Pancreatic Ductal Adenocarcinoma: Neutro-phil-Lymphocyte versus Platelet-Lymphocyte Ratio. The American Journal of Surgery, 200, 197-203. https://doi.org/10.1016/j.amjsurg.2009.08.041
|
[53]
|
Li, Z.M., Huang, J.J., Xia, Y., et al. (2012) Blood Lympho-cyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP. PLOS ONE, 7, e41658.
https://doi.org/10.1371/journal.pone.0041658
|
[54]
|
Wang, L., Wang, H., Xia, Z.J., et al. (2015) Peripheral Blood Lymphocyte to Monocyte Ratio Identifies High-Risk Adult Patients with Sporadic Burkitt Lymphoma. Annals of Hema-tology, 94, 1645-1654.
https://doi.org/10.1007/s00277-015-2427-7
|
[55]
|
Li, Y., Gu, K., Pan, Y., et al. (2014) Peripheral Blood Lympho-cyte/Monocyte Ratio at the Time of First Relapse Predicts Outcome for Patients with Relapsed or Primary Refractory Diffuse Large B-Cell Lymphoma. BMC Cancer, 14, Article No. 341. https://doi.org/10.1186/1471-2407-14-341
|
[56]
|
Li, J., Jiang, R., Liu, W.S., et al. (2013) A Large Cohort Study re-veals the Association of Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio with Favorable Prognosis in Naso-pharyngeal Carcinoma. PLOS ONE, 8, e83069.
https://doi.org/10.1371/journal.pone.0083069
|
[57]
|
Ni, X.J., Zhang, X.L., Ou-Yang, Q.W., et al. (2014) An Ele-vated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy. PLOS ONE, 9, e111886. https://doi.org/10.1371/journal.pone.0111886
|
[58]
|
Lin, G.N., Peng, J.W., Xiao, J.J., et al. (2014) Prognostic Im-pact of Circulating Monocytes and Lymphocyte-to-Monocyte Ratio on Previously Untreated Metastatic Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Doublet. Medical Oncology, 31, Article No. 70. https://doi.org/10.1007/s12032-014-0070-0
|
[59]
|
Feng, J. and Huang, Y. (2015) Low Preoperative Lymphocyte to Monocyte Ratio Predicts Poor Cancer-Specific Survival in Patients with Esophageal Squamous Cell Carcinoma. Onco-Targets and Therapy, 8, 137-145.
https://doi.org/10.2147/OTT.S73794
|
[60]
|
Deng, Q., He, B., Liu, X., et al. (2015) Prognostic Value of Pre-Operative Inflammatory Response Biomarkers in Gastric Cancer Patients and the Construction of a Predictive Model. Journal of Translational Medicine, 13, Article No. 66.
https://doi.org/10.1186/s12967-015-0409-0
|
[61]
|
Ozawa, T., Ishihara, S., Kawai, K., et al. (2015) Impact of a Lymphocyte to Monocyte Ratio in Stage IV Colorectal Cancer. Journal of Surgical Research, 199, 386-392. https://doi.org/10.1016/j.jss.2015.06.014
|
[62]
|
Stotz, M., Pichler, M., Absenger, G., et al. (2014) The Preoperative Lymphocyte to Monocyte Ratio Predicts Clinical Outcome in Patients with Stage III Colon Cancer. British Journal of Cancer, 110, 435-440.
https://doi.org/10.1038/bjc.2013.785
|
[63]
|
Qi, Q., Geng, Y., Sun, M., et al. (2015) Clinical Implications of Systemic Inflammatory Response Markers as Independent Prognostic Factors for Advanced Pancreatic Cancer. Pancreatology, 15, 145-150.
https://doi.org/10.1016/j.pan.2014.12.004
|
[64]
|
Stotz, M., Szkandera, J., Stojakovic, T., et al. (2015) The Lympho-cyte to Monocyte Ratio in Peripheral Blood Represents a Novel Prognostic Marker in Patients with Pancreatic Cancer. Clinical Chemistry and Laboratory Medicine, 53, 499-506. https://doi.org/10.1515/cclm-2014-0447
|
[65]
|
Nie, D., Gong, H., Mao, X., et al. (2019) Systemic Immune-Inflammation Index Predicts Prognosis in Patients with Epithelial Ovarian Cancer: A Retrospective Study. Gynecologic Oncology, 152, 259-264.
https://doi.org/10.1016/j.ygyno.2018.11.034
|
[66]
|
Wang, J., Yin, S. and Chen, K. (2022) Predictive Value of the Systemic Immune-Inflammation Index for the Efficacy of Neoadjuvant Chemotherapy and Prognosis in Patients with Stage III Ovarian Cancer—A Retrospective Cohort Study. Gland Surgery, 11, 1639-1646. https://doi.org/10.21037/gs-22-459
|
[67]
|
Farolfi, A., Petrone, M., Scarpi, E., et al. (2018) Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24). Targeted Oncology, 13, 469-479. https://doi.org/10.1007/s11523-018-0574-1
|
[68]
|
Wang, Y., Liu, P., Xu, Y., et al. (2015) Preoperative Neutro-phil-to-Lymphocyte Ratio Predicts Response to First-Line Platinum-Based Chemotherapy and Prognosis in Serous Ovarian Cancer. Cancer Chemotherapy and Pharmacology, 75, 255-262. https://doi.org/10.1007/s00280-014-2622-6
|
[69]
|
Williams, K.A., Labidi-Galy, S.I., Terry, K.L., et al. (2014) Prog-nostic Significance and Predictors of the Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer. Gynecologic Oncology, 132, 542-550.
https://doi.org/10.1016/j.ygyno.2014.01.026
|
[70]
|
Seckin, K.D., Karsli, M.F., Yucel, B., et al. (2016) The Utility of Tumor Markers and Neutrophil Lymphocyte Ratio in Patients with an Intraoperative Diagnosis of Mucinous Borderline Ovarian Tumor. European Journal of Obstetrics & Gynecology and Reproductive Biology, 196, 60-63. https://doi.org/10.1016/j.ejogrb.2015.10.025
|
[71]
|
Cho, H., Hur, H.W., Kim, S.W., et al. (2009) Pre-Treatment Neutrophil to Lymphocyte Ratio Is Elevated in Epithelial Ovarian Cancer and Predicts Survival after Treatment. Cancer Immunology, Immunotherapy, 58, 15-23.
https://doi.org/10.1007/s00262-008-0516-3
|
[72]
|
Feng, Z., Wen, H., Bi, R., et al. (2016) Preoperative Neutro-phil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer. PLOS ONE, 11, e156101.
https://doi.org/10.1371/journal.pone.0156101
|
[73]
|
Liontos, M., Andrikopoulou, A., Koutsoukos, K., et al. (2021) Neutrophil-to-Lymphocyte Ratio and Chemotherapy Response Score as Prognostic Markers in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy. Journal of Ovarian Research, 14, Article No. 148. https://doi.org/10.1186/s13048-021-00902-0
|
[74]
|
Wang, N., Li, C., Yang, Y., et al. (2021) The Use of Plate-let/Lymphocyte Ratio and Cancer Antigen 125 Combined with Magnetic Resonance Diffusion-Weighted Imaging in Di-agnosis of Recurrent Ovarian Cancer and Neuropathic Pain. World Neurosurgery, 149, 502-510. https://doi.org/10.1016/j.wneu.2020.11.117
|
[75]
|
Eo, W.K., Chang, H.J., Kwon, S.H., et al. (2016) The Lympho-cyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Ovarian Cancer. Journal of Cancer, 7, 289-296. https://doi.org/10.7150/jca.13432
|
[76]
|
Jeerakornpassawat, D. and Suprasert, P. (2020) Potential Predictors for Chemotherapeutic Response and Prognosis in Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients Treated with Platinum-Based Chemotherapy. Obstetrics & Gynecology Science, 63, 55-63. https://doi.org/10.5468/ogs.2020.63.1.55
|
[77]
|
Kim, H.S., Choi, H.Y., Lee, M., et al. (2016) Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study. Cancer Research and Treatment, 48, 250-258.
https://doi.org/10.4143/crt.2014.324
|
[78]
|
Cramer, D.W., Benjamin, I.W., Vitonis, A.F., et al. (2021) Differential Blood Count as Triage Tool in Evaluation of Pelvic Masses. International Journal of Gynecologic Cancer, 31, 733-743. https://doi.org/10.1136/ijgc-2019-001103
|
[79]
|
Huang, C.Y., Yang, Y.C., Wang, K.L., et al. (2016) Possible Sur-rogate Marker for an Effective Dose-Dense Chemotherapy in Treating Ovarian Cancer. Taiwanese Journal of Obstetrics and Gynecology, 55, 405-409.
https://doi.org/10.1016/j.tjog.2016.04.017
|
[80]
|
Hu, Q., Shen, G., Li, Y., et al. (2023) Lymphocyte-to-Monocyte Ratio after Primary Surgery Is an Independent Prognostic Factor for Patients with Epithelial Ovarian Cancer: A Propen-sity Score Matching Analysis. Frontiers in Oncology, 13, Article ID: 1139929. https://doi.org/10.3389/fonc.2023.1139929
|
[81]
|
Tang, Y., Hu, H.Q., Tang, Y.L., et al. (2021) Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer. Journal of Cancer, 12, 5923-5928. https://doi.org/10.7150/jca.62090
|
[82]
|
Abu-Shawer, O., Abu-Shawer, M., Hirmas, N., et al. (2019) Hematologic Markers of Distant Metastases and Poor Prognosis in Gynecological Cancers. BMC Cancer, 19, Article No. 141. https://doi.org/10.1186/s12885-019-5326-9
|
[83]
|
Kokcu, A., Kurtoglu, E., Celik, H., et al. (2014) May the Platelet to Lymphocyte Ratio Be a Prognostic Factor for Epithelial Ovarian Cancer? Asian Pacific Journal of Cancer Prevention, 15, 9781-9784.
https://doi.org/10.7314/APJCP.2014.15.22.9781
|
[84]
|
Zhao, Z., Zhao, X., Lu, J., et al. (2018) Prognostic Roles of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis of Retrospective Studies. Archives of Gynecology and Obstetrics, 297, 849-857. https://doi.org/10.1007/s00404-018-4678-8
|
[85]
|
Prodromidou, A., Andreakos, P., Kazakos, C., et al. (2017) The Diagnostic Efficacy of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer. Inflamma-tion Research, 66, 467-475.
https://doi.org/10.1007/s00011-017-1026-6
|
[86]
|
Miao, Y., Yan, Q., Li, S., et al. (2016) Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio Are Predictive of Chemotherapeutic Response and Prognosis in Epithelial Ovari-an Cancer Patients Treated with Platinum-Based Chemotherapy. Cancer Biomark, 17, 33-40. https://doi.org/10.3233/CBM-160614
|
[87]
|
Polat, M., Senol, T., Ozkaya, E., et al. (2016) Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Increase in Ovarian Tumors in the Presence of Frank Stromal Invasion. Clinical and Translational Oncology, 18, 457-463.
https://doi.org/10.1007/s12094-015-1387-7
|
[88]
|
Medina, F.F., Munoz-Casares, F.C., Arjona-Sanchez, A., et al. (2015) Postoperative Time Course and Utility of Inflammatory Markers in Patients with Ovarian Peritoneal Carcinomato-sis Treated with Neoadjuvant Chemotherapy, Cytoreductive Surgery, and HIPEC. Annals of Surgical Oncology, 22, 1332-1340.
https://doi.org/10.1245/s10434-014-4096-5
|
[89]
|
Badora-Rybicka, A., Nowara, E. and Starzyczny-Slota, D. (2016) Neutrophil-to-Lymphocyte Ratio and Platelet-to- Lymphocyte Ratio before Chemotherapy as Potential Prognostic Factors in Patients with Newly Diagnosed Epithelial Ovarian Cancer. ESMO Open, 1, e39. https://doi.org/10.1136/esmoopen-2016-000039
|
[90]
|
Li, Z., Hong, N., Robertson, M., et al. (2017) Preoperative Red Cell Distribution width and Neutrophil-to-Lymphocyte Ratio Predict Survival in Patients with Epithelial Ovarian Cancer. Scientific Reports, 7, Article No. 43001.
https://doi.org/10.1038/srep43001
|
[91]
|
Yoshida, K., Yoshikawa, N., Shirakawa, A., et al. (2019) Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Early-Stage Ovarian Clear-Cell Carcinoma. Journal of Gynecologic Oncology, 30, e85.
https://doi.org/10.3802/jgo.2019.30.e85
|
[92]
|
Raungkaewmanee, S., Tangjitgamol, S., Manusirivithaya, S., et al. (2012) Platelet to Lymphocyte Ratio as a Prognostic Factor for Epithelial Ovarian Cancer. Journal of Gynecologic On-cology, 23, 265-273.
https://doi.org/10.3802/jgo.2012.23.4.265
|
[93]
|
Topcu, H.O., Guzel, A.I., Ozer, I., et al. (2014) Comparison of Neutrophil/Lymphocyte and Platelet/ Lymphocyte Ratios for Predicting Malignant Potential of Suspicious Ovarian Masses in Gynecology Practice. Asian Pacific Journal of Cancer Prevention, 15, 6239-6241. https://doi.org/10.7314/APJCP.2014.15.15.6239
|
[94]
|
Zhang, M., Cheng, S., Jin, Y., et al. (2021) Roles of CA125 in Diagnosis, Prediction, and Oncogenesis of Ovarian Cancer. Biochimica et Biophysica Acta, 1875, Article ID: 188503.
https://doi.org/10.1016/j.bbcan.2021.188503
|